T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
JPMorgan Chase
JPM
|
+$1.7B |
| 2 |
Verizon
VZ
|
+$1.36B |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$1.31B |
| 4 |
US Bancorp
USB
|
+$1.29B |
| 5 |
Merck
MRK
|
+$1.23B |
Top Sells
| 1 |
Amazon
AMZN
|
+$5.38B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$4.57B |
| 3 |
Tesla
TSLA
|
+$3.67B |
| 4 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$3.44B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.43B |
Sector Composition
| 1 | Technology | 26.72% |
| 2 | Healthcare | 19.64% |
| 3 | Financials | 12.69% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
651
Zebra Technologies
ZBRA
$15.6B
| $51.8M | 0.01% |
202,160
-9,556
| -5% | -$2.45M |
|
652
Rentokil
RTO
$12.8B
| $51.3M | 0.01% |
+1,664,744
| New | +$51.3M |
|
653
Coca-Cola Consolidated
COKE
$10.5B
| $51.2M | 0.01% |
998,710
+3,570
| +0.4% | +$183K |
|
|
NARI
654
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $51M | 0.01% |
802,977
+139,929
| +21% | +$8.89M |
|
655
Deckers Outdoor
DECK
$16.9B
| $51M | 0.01% |
766,380
-130,530
| -15% | -$8.68M |
|
656
Fortune Brands Innovations
FBIN
$7.05B
| $50.9M | 0.01% |
891,435
+380,558
| +74% | +$21.7M |
|
657
Cytokinetics
CYTK
$6.22B
| $50.8M | 0.01% |
1,107,861
+14,414
| +1% | +$660K |
|
658
Builders FirstSource
BLDR
$15.5B
| $50.4M | 0.01% |
776,649
-180,997
| -19% | -$11.7M |
|
659
Watts Water Technologies
WTS
$9.29B
| $50.1M | 0.01% |
342,416
+2,000
| +0.6% | +$292K |
|
|
RXDX
660
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $50.1M | 0.01% |
455,059
+359,970
| +379% | +$39.6M |
|
661
Parker-Hannifin
PH
$97B
| $49.9M | 0.01% |
171,373
+1,318
| +0.8% | +$384K |
|
662
Cboe Global Markets
CBOE
$24.6B
| $49.8M | 0.01% |
396,540
+664
| +0.2% | +$83.3K |
|
663
Ryan Specialty Holdings
RYAN
$6.52B
| $49.4M | 0.01% |
1,191,114
+90,261
| +8% | +$3.75M |
|
664
Power Integrations
POWI
$2.49B
| $49.3M | 0.01% |
686,961
+123
| +0% | +$8.82K |
|
665
PTC Therapeutics
PTCT
$4.64B
| $49M | 0.01% |
1,284,389
-182,804
| -12% | -$6.98M |
|
666
Vail Resorts
MTN
$5.37B
| $49M | 0.01% |
205,540
+12,789
| +7% | +$3.05M |
|
667
Fortive
FTV
$16.2B
| $48.9M | 0.01% |
760,685
-1,144,968
| -60% | -$73.6M |
|
668
Procept Biorobotics
PRCT
$2.09B
| $48.5M | 0.01% |
1,168,617
+97,383
| +9% | +$4.05M |
|
669
EPAM Systems
EPAM
$8.53B
| $48.5M | 0.01% |
148,039
-2,341
| -2% | -$767K |
|
|
IAA
670
DELISTED
IAA, Inc. Common Stock
IAA
| $48.4M | 0.01% |
1,210,275
-32,228
| -3% | -$1.29M |
|
671
SM Energy
SM
$3.14B
| $48.2M | 0.01% |
1,385,102
+85,166
| +7% | +$2.97M |
|
672
Prudential Financial
PRU
$37.2B
| $48.2M | 0.01% |
484,685
-6,009
| -1% | -$598K |
|
673
Watsco
WSO
$15.8B
| $47.5M | 0.01% |
190,328
-13,624
| -7% | -$3.4M |
|
|
DHR.PRB
674
DELISTED
Danaher Corporation 5.00% Mandatory Convertible Preferred Stock, Series B
DHR.PRB
| – | – |
0
| – | -$51.4M |
|
675
iRhythm Technologies
IRTC
$5.85B
| $47.3M | 0.01% |
504,695
-187,883
| -27% | -$17.6M |
|